NICE backs Braftovi for BRAF-positive colorectal cancer
admin 24th November 2020 Uncategorised 0Positive recommendation follows initial rejection in September More: NICE backs Braftovi for BRAF-positive colorectal cancer Source: News
read more
Positive recommendation follows initial rejection in September More: NICE backs Braftovi for BRAF-positive colorectal cancer Source: News
read moreLess-frequent, fixed-dose use approved for two cancer indications More: FDA approves new dosing option for AZ’s Imfinzi Source: News
read moreMenQuadfi approved for vaccination in individuals 12 months of age or older More: Sanofi’s meningococcal vaccine wins EU approval Source: News
read moreIowa State taps device maker Zeteo for early work on nasal spray COVID-19 vaccine fkansteiner Mon, 11/23/2020 – 17:02 More: Iowa State taps device maker Zeteo for early work on nasal spray COVID-19 vaccine Source: fierce
read moreRB brand Mucinex hopes to hype doctors with new push for online ratings bbulik Mon, 11/23/2020 – 15:03 More: RB brand Mucinex hopes to hype doctors with new push for online ratings Source: fierce
read moreModerna to file COVID-19 shot for emergency nod in November, with Pfizer rollout pegged for early next month: Slaoui fkansteiner Mon, 11/23/2020 – 10:49 More: Moderna to file COVID-19 shot for emergency nod in November, with Pfizer rollout pegged for
read more© 1994 - 2026 B.M. Pharmaceuticals